Pharmgate LLC Sustainability Profile
Pharmgate LLC, headquartered in the United States, is a prominent player in the agricultural and pharmaceutical industries, specialising in the development and distribution of innovative animal health products. Founded in 2015, the company has rapidly established itself as a trusted provider of high-quality solutions for livestock and poultry, focusing on enhancing animal welfare and productivity. With a strong operational presence across North America and beyond, Pharmgate offers a diverse range of core products, including vaccines, pharmaceuticals, and nutritional supplements. What sets Pharmgate apart is its commitment to research and development, ensuring that its offerings are both effective and safe for animal use. The company has achieved significant milestones, positioning itself as a leader in the market, recognised for its dedication to quality and customer satisfaction.
DitchCarbon Score
How does Pharmgate LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmgate LLC's score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmgate LLC's reported carbon emissions
Pharmgate LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Jinhe Biotechnology CO., LTD., which may influence its climate commitments and emissions reporting. As of now, Pharmgate LLC has not established any documented reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of specific targets suggests that the company may still be in the early stages of formalising its climate strategy. Given the absence of direct emissions data and reduction commitments, it is essential for Pharmgate LLC to consider developing a comprehensive climate action plan. This could include setting measurable targets for reducing greenhouse gas emissions across all scopes, particularly focusing on Scope 1 and Scope 2 emissions, which pertain to direct emissions from owned or controlled sources and indirect emissions from the generation of purchased energy, respectively. In summary, while Pharmgate LLC does not currently report specific emissions figures or reduction targets, its affiliation with Jinhe Biotechnology CO., LTD. may provide a framework for future climate initiatives. The company is encouraged to adopt industry-standard practices to enhance its sustainability efforts and align with global climate goals.
How Carbon Intensive is Pharmgate LLC's Industry?
How Carbon Intensive is Pharmgate LLC's Location?
Pharmgate LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmgate LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
